Skip to content

Clinical trials

Squamous Cell Carcinoma of Head and Neck trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Country / region: South Korea Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20082
20092
20111
20122
20133
20142
20155
20164
20178
20184
20198
202013
202115
20229
20239
202411
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Active, not recruiting24
Recruiting24
Terminated16
Unknown status8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Yonsei University7
AbbVie5
Merck Sharp & Dohme LLC5
Novartis Pharmaceuticals5
GlaxoSmithKline4
Pfizer4
Seoul National University Hospital4
Merus B.V.3
ALX Oncology Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck109
Head and Neck Neoplasms30
Carcinoma, Non-Small-Cell Lung27
Melanoma17
Stomach Neoplasms15
Neoplasm Metastasis14
Neoplasms14
Colorectal Neoplasms13
Carcinoma, Renal Cell12
Esophageal Squamous Cell Carcinoma12

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.